Screening Cysteine Protease inhibitors for NTD drug discovery

Status
Completed
Start date
End date
Start stage
Screening
End stage
Hit ID
Disease
Soil-transmitted helminthiasis (STH)
Schistosomiasis
Malaria
Chagas disease
Human African trypanosomiasis (HAT)
Research areas
Drug

Cathepsins have been identified as potential drug targets across a range of infectious organisms. Drs. Caffrey, McKerrow, and Dr. Rosenthal were interested in screening cathepsin inhibitors against a selection of parasitic organisms. BVGH connected them with AstraZeneca, which provided cysteine protease inhibitors for screening against both human and parasitic enzyme targets.